•Lexitas acquires Erie Retina Research to expand ophthalmic trials•NeuroVision expands retinal imaging-based neurodegenerative disease detection with new acquisition •Vitreous floaters may predict RD development•Outlook Therapeutics wins FDA appeal for wet AMD BLA •PECAA debuts private label 1-day contact lenses developed by CooperVision•Lexitas acquires Erie Retina Research to expand ophthalmic trials•NeuroVision expands retinal imaging-based neurodegenerative disease detection with new acquisition •Vitreous floaters may predict RD development•Outlook Therapeutics wins FDA appeal for wet AMD BLA •PECAA debuts private label 1-day contact lenses developed by CooperVision
HEADLINES
FEATURED
Integration follows after parent company Revenio announced plans to combine both arsenals of ophthalmic medical device and imaging solutions.
Earn FREE CE 24/7 with Courses by Eyes On Eyecare
Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.
